Skip to content
Home/Companies/Biotech/Actithera
AC

Actithera

Biotech·France·Active·1yr hold

Actithera is a healthcare / biotech company, headquartered in France.

Entry
2025
Hold
1yr
Status
Active
Est. EV
–

Who owns Actithera?

Actithera is currently owned by Sofinnova Partners through Sofinnova Capital XI (2025 vintage), since 2025. Across its history, Actithera has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Most recent investor
Sofinnova Partners
Sofinnova Capital XI · 2025 · Life Sciences VC
2 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare / Biotech

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by 4Bio Partners and Sofinnova Partners since 2025.
Co-invest · 2 holders · 2025 · present
4Bio Partners
4Bio PartnersActive
2025 · present · 4BIO Ventures III · 2022 · Life Sciences VC
MOIC
–
Sofinnova Partners
Sofinnova PartnersActive
2025 · present · Sofinnova Capital XI · 2025 · Life Sciences VC
MOIC
–

More from Sofinnova Capital XI

Other portfolio companies in the same fund.

BIONYRA PHARMA
Active
HealthcareFrance· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings